New combo pill aims to curb weight gain in teens on antipsychotics

NCT ID NCT05303064

First seen Jun 27, 2026 · Last updated Aug 14, 2026 · Updated 1 time

Summary

This study tests whether a combination drug called OLZ/SAM (olanzapine plus samidorphan) causes less weight gain than olanzapine alone in teenagers with schizophrenia or bipolar I disorder. About 220 teens aged 10-17 will take either the combo or olanzapine for 52 weeks. The main goal is to see if the combo leads to a smaller increase in body mass index (BMI).

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
OLZ/SAM (olanzapine and samidorphan combination)
What this could lead to
If successful, this could offer a way to control psychiatric symptoms with less weight gain, improving long-term health for teens.
What could go wrong
This is an early Phase 3 trial with only 220 participants, so results may not apply to everyone. Weight gain may still occur, and side effects are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BIPOLAR I DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Alkermes Investigational Site

    WITHDRAWN

    Kinston, North Carolina, 28504, United States

  • Alkermes Investigational Site

    RECRUITING

    Richmond, Virginia, 23220, United States

  • Alkermes Investigator Site

    RECRUITING

    Dothan, Alabama, 36303, United States

  • Alkermes Investigator Site

    RECRUITING

    Little Rock, Arkansas, 72204, United States

  • Alkermes Investigator Site

    WITHDRAWN

    Encino, California, 91316, United States

  • Alkermes Investigator Site

    RECRUITING

    Stanford, California, 94305, United States

  • Alkermes Investigator Site

    WITHDRAWN

    Upland, California, 91786, United States

  • Alkermes Investigator Site

    WITHDRAWN

    Colorado Springs, Colorado, 80910, United States

  • Alkermes Investigator Site

    ACTIVE_NOT_RECRUITING

    Denver, Colorado, 80202, United States

  • Alkermes Investigator Site

    WITHDRAWN

    Hartford, Connecticut, 06106, United States

  • Alkermes Investigator Site

    RECRUITING

    Washington D.C., District of Columbia, 20010, United States

  • Alkermes Investigator Site

    WITHDRAWN

    Miami, Florida, 33155, United States

  • Alkermes Investigator Site

    RECRUITING

    Miami Lakes, Florida, 33016, United States

  • Alkermes Investigator Site

    RECRUITING

    Decatur, Georgia, 30030, United States

  • Alkermes Investigator Site

    RECRUITING

    Chicago, Illinois, 60611, United States

  • Alkermes Investigator Site

    RECRUITING

    Indianapolis, Indiana, 46202, United States

  • Alkermes Investigator Site

    RECRUITING

    Saint Charles, Missouri, 63304, United States

  • Alkermes Investigator Site

    RECRUITING

    Lincoln, Nebraska, 68526, United States

  • Alkermes Investigator Site

    WITHDRAWN

    Omaha, Nebraska, 68198, United States

  • Alkermes Investigator Site

    WITHDRAWN

    Paramus, New Jersey, 07652, United States

  • Alkermes Investigator Site

    RECRUITING

    New York, New York, 10016, United States

  • Alkermes Investigator Site

    RECRUITING

    Cincinnati, Ohio, 45219, United States

  • Alkermes Investigator Site

    RECRUITING

    West Chester, Ohio, 45069, United States

  • Alkermes Investigator Site

    TERMINATED

    DeSoto, Texas, 75115, United States

  • Alkermes Investigator Site

    WITHDRAWN

    Fort Worth, Texas, 76104, United States

  • Alkermes Investigator Site

    RECRUITING

    Everett, Washington, 98201, United States

  • Alkermes Investigator Site

    RECRUITING

    La Plata, Buenos Aires, 1900, Argentina

  • Alkermes Investigator Site

    RECRUITING

    La Plata, Buenos Aires, C1199ABB, Argentina

  • Alkermes Investigator Site

    RECRUITING

    Buenos Aires, C1133AAH, Argentina

  • Alkermes Investigator Site

    RECRUITING

    Córdoba, X5003DCE, Argentina

  • Alkermes Investigator Site

    RECRUITING

    Mendoza, 5500, Argentina

  • Alkermes Investigator Site

    RECRUITING

    Fortaleza, Ceará, 60430-140, Brazil

  • Alkermes Investigator Site

    RECRUITING

    Curitiba, Paraná, 80240-280, Brazil

  • Alkermes Investigator Site

    RECRUITING

    Goiânia, 74093-040, Brazil

  • Alkermes Investigator Site

    RECRUITING

    Rio de Janeiro, 22270-060, Brazil

  • Alkermes Investigator Site

    RECRUITING

    São Paulo, 01228-000, Brazil

  • Alkermes Investigator Site

    RECRUITING

    São Paulo, 05403-010, Brazil

  • Alkermes Investigator Site

    RECRUITING

    Barranquilla, 110121, Colombia

  • Alkermes Investigator Site

    RECRUITING

    Bello, 51053, Colombia

  • Alkermes Investigator Site

    ACTIVE_NOT_RECRUITING

    Bogotá, 111166, Colombia

  • Alkermes Investigator Site

    RECRUITING

    Bogotá, 80020, Colombia

  • Alkermes Investigator Site

    RECRUITING

    Pereira, 660003, Colombia

  • Alkermes Investigator Site

    RECRUITING

    Culiacán, 80230, Mexico

  • Alkermes Investigator Site

    RECRUITING

    Estado de México, C.P. 07000, Mexico

  • Alkermes Investigator Site

    RECRUITING

    León, 37000, Mexico

  • Alkermes Investigator Site

    RECRUITING

    Monterrey, 64620, Mexico

  • Alkermes Investigator Site

    RECRUITING

    Monterrey, 64710, Mexico

More trials for these conditions

Other studies related to the condition(s) this trial covers.